These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9714980)

  • 1. Primary Sjögren's syndrome followed by chronic myelogenous leukemia: a case report with a ten year history.
    Minowa R; Miyagawa S; Fukumoto T; Majima T; Shimoyama T; Fujimura Y; Shirai T
    J Dermatol; 1998 Jul; 25(7):460-4. PubMed ID: 9714980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute iritis associated with primary Sjögren's syndrome and high-titer anti-SS-A/Ro and anti-SS-B/La antibodies. Treatment with combination immunosuppressive therapy.
    Bridges AJ; Burns RP
    Arthritis Rheum; 1992 May; 35(5):560-3. PubMed ID: 1575789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Galimberti M; Polchi P; Lucarelli G; Angelucci E; Baronciani D; Giardini C; Gaziev D; Erer B; Ripalti M; Rapa S
    Bone Marrow Transplant; 1994 Feb; 13(2):197-201. PubMed ID: 8205089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ophthalmologic findings in graft versus host disease (GvHD)].
    Käsmann B; Ruprecht KW
    Klin Monbl Augenheilkd; 1993 Jun; 202(6):491-9. PubMed ID: 8397319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
    Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
    Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
    Brodsky I; Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos BR; Tutschka P
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):27-31; quiz 32. PubMed ID: 8342072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
    Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
    Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous manifestations of primary Sjögren's syndrome].
    Nishiyama S; Miyawaki S; Hashimoto T
    Nihon Rinsho; 1995 Oct; 53(10):2551-6. PubMed ID: 8531372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
    Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
    J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma.
    Rouquette-Gally AM; Boyeldieu D; Gluckman E; Abuaf N; Combrisson A
    Br J Haematol; 1987 May; 66(1):45-7. PubMed ID: 3297128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
    Alexander EL; Arnett FC; Provost TT; Stevens MB
    Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of complete heart block in an adult patient with Sjögren's syndrome and anti-Ro/SS-A autoantibodies.
    Lee LA; Pickrell MB; Reichlin M
    Arthritis Rheum; 1996 Aug; 39(8):1427-9. PubMed ID: 8702455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary Sjögren's syndrome and glomerulonephritis].
    Tholl U; Hartung K; Helmchen U; Anlauf M
    Dtsch Med Wochenschr; 1998 Dec; 123(51-52):1541-6. PubMed ID: 9893680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary Sjögren's syndrome revealing cerebellar syndrome].
    Meriglier E; Debouverie O; Walter-Lepage A; Brigaud A; Beuvon C; Luca L
    Rev Neurol (Paris); 2015 Sep; 171(8-9):674-6. PubMed ID: 25912281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.